BKA-073 exhibited potent antitumor activity against lung cancer via induction of Bak activation (i.e. oligomerization) and apoptotic cell death in xenografts derived from either a lung cancer cell line or a patient-derived SCLC tumor. The gene discussed is BAK1; the disease is small cell lung carcinoma.